{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5078, "recent_count": 15, "transaction_limit": 160, "filters": {"q": "", "ticker": "AKTX", "sector": "", "industry": "", "side": "", "start": "2026-06-18", "end": "2026-08-02"}, "summary": {"total": 15, "acquisition_count": 15, "disposal_count": 0, "acquisition_value": 497017.016, "acquisition_value_label": "$497.0K", "disposal_value": 0.0, "disposal_value_label": "$0", "net_value": 497017.016, "net_value_label": "$497.0K", "flow_tone": "positive", "largest_value_label": "$249.9K", "top_sector": "Healthcare", "window_label": "18 Jun 2026 to 02 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 15, "value": "497017.0160", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$497.0K"}], "days": [{"transaction_date": "2026-06-24", "acquisitions": 9, "disposals": 0, "total": 9, "bar_width": 100.0}, {"transaction_date": "2026-07-07", "acquisitions": 6, "disposals": 0, "total": 6, "bar_width": 66.7}], "side_mix": {"acquisitions": 15, "disposals": 0, "acquisition_share": 100.0, "disposal_share": 0.0}}, "company_flows": [{"symbol": "AKTX", "name": "Akari Therapeutics PLC", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-07", "acquisitions": 15, "disposals": 0, "acquired_value": 497017.016, "acquired_value_label": "$497.0K", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 497017.016, "net_value_label": "$497.0K", "acquisition_share": 100.0, "disposal_share": 0.0, "detail_url": "https://sharemaestro.com/insider-activity/company/aktx/", "research_links": {"chart": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/", "report": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/report/", "factor": "/factors/ticker/fee8a675-5ed9-4b93-a020-12b4b308e34e/"}}], "company_overview": [{"symbol": "AKTX", "name": "Akari Therapeutics PLC", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-07", "filings": 15, "acquisitions": 15, "disposals": 0, "acquired_value": 497017.016, "acquired_value_label": "$497.0K", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 497017.016, "net_value_label": "$497.0K", "acquisition_share": 100.0, "disposal_share": 0.0, "tone": "Acquisition-led", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/aktx/", "research_links": {"chart": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/", "report": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/report/", "factor": "/factors/ticker/fee8a675-5ed9-4b93-a020-12b4b308e34e/"}}], "transactions": [{"symbol": "AKTX", "name": "Akari Therapeutics PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "PATEL, SAMIR RASHMIKANT", "executive_title": "Director, 10% Owner", "security_type": "Pre-Funded Warrant to purchase ADSs", "side_code": "A", "side": "Acquisition", "shares": 15466.0, "share_price": 16.16, "transaction_value": 249930.56, "fetched_at": "2026-07-28T21:48:05.551485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/aktx/", "research_links": {"chart": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/", "report": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/report/", "factor": "/factors/ticker/fee8a675-5ed9-4b93-a020-12b4b308e34e/"}}, {"symbol": "AKTX", "name": "Akari Therapeutics PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "PATEL, SAMIR RASHMIKANT", "executive_title": "Director, 10% Owner", "security_type": "Pre-Funded Warrant to purchase ADSs", "side_code": "A", "side": "Acquisition", "shares": 5799.0, "share_price": 16.16, "transaction_value": 93711.84, "fetched_at": "2026-07-28T21:48:05.549723+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/aktx/", "research_links": {"chart": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/", "report": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/report/", "factor": "/factors/ticker/fee8a675-5ed9-4b93-a020-12b4b308e34e/"}}, {"symbol": "AKTX", "name": "Akari Therapeutics PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "PATEL, SAMIR RASHMIKANT", "executive_title": "Director, 10% Owner", "security_type": "Pre-Funded Warrant to purchase American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 1209.0, "share_price": 32.0, "transaction_value": 38688.0, "fetched_at": "2026-07-28T21:48:05.537268+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/aktx/", "research_links": {"chart": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/", "report": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/report/", "factor": "/factors/ticker/fee8a675-5ed9-4b93-a020-12b4b308e34e/"}}, {"symbol": "AKTX", "name": "Akari Therapeutics PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "PATEL, SAMIR RASHMIKANT", "executive_title": "Director, 10% Owner", "security_type": "American Depositary Shares representing Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 1209.0, "share_price": 8.0, "transaction_value": 9672.0, "fetched_at": "2026-07-28T21:48:05.547876+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/aktx/", "research_links": {"chart": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/", "report": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/report/", "factor": "/factors/ticker/fee8a675-5ed9-4b93-a020-12b4b308e34e/"}}, {"symbol": "AKTX", "name": "Akari Therapeutics PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "PATEL, SAMIR RASHMIKANT", "executive_title": "Director, 10% Owner", "security_type": "American Depositary Shares representing Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 15466.0, "share_price": 0.0004, "transaction_value": 6.1864, "fetched_at": "2026-07-28T21:48:05.545789+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/aktx/", "research_links": {"chart": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/", "report": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/report/", "factor": "/factors/ticker/fee8a675-5ed9-4b93-a020-12b4b308e34e/"}}, {"symbol": "AKTX", "name": "Akari Therapeutics PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "PATEL, SAMIR RASHMIKANT", "executive_title": "Director, 10% Owner", "security_type": "American Depositary Shares representing Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 5799.0, "share_price": 0.0004, "transaction_value": 2.3196, "fetched_at": "2026-07-28T21:48:05.543154+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/aktx/", "research_links": {"chart": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/", "report": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/report/", "factor": "/factors/ticker/fee8a675-5ed9-4b93-a020-12b4b308e34e/"}}, {"symbol": "AKTX", "name": "Akari Therapeutics PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "FARAG, KAMEEL D.", "executive_title": "Interim CFO", "security_type": "American Depositary Shares representing Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 7353.0, "share_price": 3.74, "transaction_value": 27500.22, "fetched_at": "2026-07-14T11:05:30.215768+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/aktx/", "research_links": {"chart": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/", "report": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/report/", "factor": "/factors/ticker/fee8a675-5ed9-4b93-a020-12b4b308e34e/"}}, {"symbol": "AKTX", "name": "Akari Therapeutics PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "FARAG, KAMEEL D.", "executive_title": "Interim CFO", "security_type": "American Depositary Shares representing Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 1395.0, "share_price": 9.32, "transaction_value": 13001.4, "fetched_at": "2026-07-14T11:05:30.238391+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/aktx/", "research_links": {"chart": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/", "report": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/report/", "factor": "/factors/ticker/fee8a675-5ed9-4b93-a020-12b4b308e34e/"}}, {"symbol": "AKTX", "name": "Akari Therapeutics PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "FARAG, KAMEEL D.", "executive_title": "Interim CFO", "security_type": "American Depositary Shares representing Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 3725.0, "share_price": 3.49, "transaction_value": 13000.25, "fetched_at": "2026-07-14T11:05:30.222943+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/aktx/", "research_links": {"chart": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/", "report": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/report/", "factor": "/factors/ticker/fee8a675-5ed9-4b93-a020-12b4b308e34e/"}}, {"symbol": "AKTX", "name": "Akari Therapeutics PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "FARAG, KAMEEL D.", "executive_title": "Interim CFO", "security_type": "American Depositary Shares representing Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 1000.0, "share_price": 13.0, "transaction_value": 13000.0, "fetched_at": "2026-07-14T11:05:30.209226+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/aktx/", "research_links": {"chart": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/", "report": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/report/", "factor": "/factors/ticker/fee8a675-5ed9-4b93-a020-12b4b308e34e/"}}, {"symbol": "AKTX", "name": "Akari Therapeutics PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "FARAG, KAMEEL D.", "executive_title": "Interim CFO", "security_type": "American Depositary Shares representing Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 2539.0, "share_price": 5.12, "transaction_value": 12999.68, "fetched_at": "2026-07-14T11:05:30.227266+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/aktx/", "research_links": {"chart": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/", "report": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/report/", "factor": "/factors/ticker/fee8a675-5ed9-4b93-a020-12b4b308e34e/"}}, {"symbol": "AKTX", "name": "Akari Therapeutics PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "FARAG, KAMEEL D.", "executive_title": "Interim CFO", "security_type": "American Depositary Shares representing Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 1570.0, "share_price": 8.28, "transaction_value": 12999.6, "fetched_at": "2026-07-14T11:05:30.233089+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/aktx/", "research_links": {"chart": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/", "report": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/report/", "factor": "/factors/ticker/fee8a675-5ed9-4b93-a020-12b4b308e34e/"}}, {"symbol": "AKTX", "name": "Akari Therapeutics PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "FARAG, KAMEEL D.", "executive_title": "Interim CFO", "security_type": "American Depositary Shares representing Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 1248.0, "share_price": 10.02, "transaction_value": 12504.96, "fetched_at": "2026-07-14T11:05:30.196203+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/aktx/", "research_links": {"chart": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/", "report": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/report/", "factor": "/factors/ticker/fee8a675-5ed9-4b93-a020-12b4b308e34e/"}}, {"symbol": "AKTX", "name": "Akari Therapeutics PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "GASLIGHTWALA, ABIZER", "executive_title": "Director, CEO", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 5500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:05:30.206586+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/aktx/", "research_links": {"chart": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/", "report": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/report/", "factor": "/factors/ticker/fee8a675-5ed9-4b93-a020-12b4b308e34e/"}}, {"symbol": "AKTX", "name": "Akari Therapeutics PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "GASLIGHTWALA, ABIZER", "executive_title": "Director, CEO", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 15563.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:05:30.203803+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/aktx/", "research_links": {"chart": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/", "report": "/terminal/fee8a675-5ed9-4b93-a020-12b4b308e34e/report/", "factor": "/factors/ticker/fee8a675-5ed9-4b93-a020-12b4b308e34e/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}